Skip to main content
Clinical Trials/IRCT2013071914056N1
IRCT2013071914056N1
Completed
Phase 2

Comparison of muscular relaxation quality between the combination of remifentanil-atracurium and succinylcholine in rapid sequence induction intubation

Arak University of Medical Sciences, Vice Chancellor for Research0 sites70 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Intubation.
Sponsor
Arak University of Medical Sciences, Vice Chancellor for Research
Enrollment
70
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Arak University of Medical Sciences, Vice Chancellor for Research

Eligibility Criteria

Inclusion Criteria

  • Age between 15\-65 years old; Candidate for hernioraphy or elective limb orthopedic surgeriy; ASA class I and II; Body mass index of less than 26; Mallampati score 1 and 2\.
  • Exclusion criteria: Mallampati score of 3 or more; patients with neuromuscular diseases; Family history of malignant hyperthermia; Family history of pseudocholinesterase deficiency; Pregnancy; Sensitivity to study medications.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials